dc.contributor.author
Xu, Mei
dc.contributor.author
Lu, Yong-Ping
dc.contributor.author
Hasan, Ahmed Abdallah
dc.contributor.author
Hocher, Berthold
dc.date.accessioned
2018-06-08T10:28:37Z
dc.date.available
2017-08-31T12:42:55.172Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/20499
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-23802
dc.description.abstract
Background/Aims: A recent study revealed that global overexpression of ET-1
causes a slight reduction in systemic blood pressure. Moreover, heterozygous
ET-1 knockout mice are hypertensive. The role of ET-1 in human hypertension
was so far not addressed by a strict meta-analysis of published human clinical
studies. Methods: We included studies published between January 1, 1990 and
February 28, 2017. We included case control studies analyzing untreated
essential hypertension or hypertensive patients where antihypertensive
medication was discontinued for at least two weeks. Based on the principle of
Cochrane systematic reviews, case control studies (CCSs) in PubMed (Medline)
and Google Scholar designed to identify the role of endothelin-1 (ET-1) in the
pathophysiological of hypertension were screened. Review Manager Version 5.0
(Rev-Man 5.0) was applied for statistical analysis. Mean difference and 95%
confidence interval (CI) were shown in inverse variance (IV) fixed-effects
model or IV random-effects models. Results: Eleven studies fulfilling our in-
and exclusion criteria were eligible for this meta-analysis. These studies
included 450 hypertensive patients and 328 controls. Our meta-analysis
revealed that ET-1 plasma concentrations were higher in hypertensive patients
as compared to the control patients [mean difference between groups 1.57
pg/mL, 95%CI [0.47∼2.68, P = 0.005]. These finding were driven by patients
having systolic blood pressure higher than 160 mmHg and diastolic blood
pressure higher than 100 mmHg. Conclusions: This meta-analysis showed that
hypertensive patients do have elevated plasma ET-1 concentrations. This
finding is driven by those patients with high systolic/diastolic blood
pressure. Given that the ET-1 gene did not appear in any of the whole genome
association studies searching for hypertension associated gene loci, it is
very likely that the elevated plasma ET-1 concentrations in hypertensive
patients are secondary to hypertension and may reflect endothelial cell
damage.
en
dc.rights.uri
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Plasma ET-1 Concentrations are Elevated in Patients with Hypertension – Meta-
Analysis of Clinical Studies
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Kidney Blood Press Res. - 42 (2017),2, S. 304-313
dcterms.bibliographicCitation.doi
10.1159/000477572
dcterms.bibliographicCitation.url
http://doi.org/10.1159/000477572
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000027744
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000008675
dcterms.accessRights.openaire
open access